- Home
- TNC vs RCKT Comparison
TNC vs RCKT Comparison
Compare TNC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNC
- RCKT
- Stock Information
- Founded
- TNC 1870
- RCKT 1999
- Country
- TNC United States
- RCKT United States
- Employees
- TNC N/A
- RCKT N/A
- Industry
- TNC Industrial Machinery/Components
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- TNC Industrials
- RCKT Health Care
- Exchange
- TNC Nasdaq
- RCKT Nasdaq
- Market Cap
- TNC 1.4B
- RCKT 264.0M
- IPO Year
- TNC N/A
- RCKT N/A
- Fundamental
- Price
- TNC $83.65
- RCKT $2.99
- Analyst Decision
- TNC Strong Buy
- RCKT Buy
- Analyst Count
- TNC 1
- RCKT 13
- Target Price
- TNC $125.00
- RCKT $18.50
- AVG Volume (30 Days)
- TNC 145.0K
- RCKT 3.8M
- Earning Date
- TNC 08-07-2025
- RCKT 08-04-2025
- Dividend Yield
- TNC 1.41%
- RCKT N/A
- EPS Growth
- TNC N/A
- RCKT N/A
- EPS
- TNC 3.58
- RCKT N/A
- Revenue
- TNC $1,265,700,000.00
- RCKT N/A
- Revenue This Year
- TNC N/A
- RCKT N/A
- Revenue Next Year
- TNC $4.25
- RCKT N/A
- P/E Ratio
- TNC $23.30
- RCKT N/A
- Revenue Growth
- TNC 1.35
- RCKT N/A
- 52 Week Low
- TNC $67.32
- RCKT $2.19
- 52 Week High
- TNC $110.45
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- TNC 70.70
- RCKT 45.55
- Support Level
- TNC $80.70
- RCKT $2.76
- Resistance Level
- TNC $84.98
- RCKT $3.24
- Average True Range (ATR)
- TNC 1.80
- RCKT 0.19
- MACD
- TNC 0.54
- RCKT 0.17
- Stochastic Oscillator
- TNC 87.89
- RCKT 74.85
About TNC Tennant Company
Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.